Literature DB >> 19558368

DNA damage signalling recruits RREB-1 to the p53 tumour suppressor promoter.

Hanshao Liu1, Hoi Chin Hew, Zheng-Guang Lu, Tomoko Yamaguchi, Yoshio Miki, Kiyotsugu Yoshida.   

Abstract

Transcriptional regulation of the p53 tumour suppressor gene plays an important role in the control of the expression of various target genes involved in the DNA damage response. However, the molecular basis of this regulation remains obscure. In the present study we demonstrate that RREB-1 (Ras-responsive-element-binding protein-1) efficiently binds to the p53 promoter via the p53 core promoter element and transactivates p53 expression. Silencing of RREB-1 significantly reduces p53 expression at both the mRNA and the protein levels. Notably, disruption of RREB-1-mediated p53 transcription suppresses the expression of the p53 target genes. We also show that, upon exposure to genotoxic stress, RREB-1 controls apoptosis in a p53-dependent manner. These findings provide evidence that RREB-1 participates in modulating p53 transcription in response to DNA damage.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19558368     DOI: 10.1042/BJ20090342

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  22 in total

1.  The ras responsive transcription factor RREB1 is a novel candidate gene for type 2 diabetes associated end-stage kidney disease.

Authors:  Jason A Bonomo; Meijian Guan; Maggie C Y Ng; Nicholette D Palmer; Pamela J Hicks; Jacob M Keaton; Janice P Lea; Carl D Langefeld; Barry I Freedman; Donald W Bowden
Journal:  Hum Mol Genet       Date:  2014-07-15       Impact factor: 6.150

2.  Evidence for changes in RREB-1, ZIP3, and Zinc in the early development of pancreatic adenocarcinoma.

Authors:  Leslie C Costello; Jing Zou; Mohamed Mokhtar Desouki; Renty B Franklin
Journal:  J Gastrointest Cancer       Date:  2012-12

3.  Decreased zinc and downregulation of ZIP3 zinc uptake transporter in the development of pancreatic adenocarcinoma.

Authors:  Leslie C Costello; Bernard A Levy; Mohamed M Desouki; Jing Zou; Omar Bagasra; Leslie A Johnson; Nader Hanna; Renty B Franklin
Journal:  Cancer Biol Ther       Date:  2011-08-15       Impact factor: 4.742

Review 4.  A comprehensive review of the role of zinc in normal prostate function and metabolism; and its implications in prostate cancer.

Authors:  Leslie C Costello; Renty B Franklin
Journal:  Arch Biochem Biophys       Date:  2016-04-27       Impact factor: 4.013

5.  RREB1 transcription factor splice variants in urologic cancer.

Authors:  Matthew D Nitz; Michael A Harding; Steven C Smith; Shibu Thomas; Dan Theodorescu
Journal:  Am J Pathol       Date:  2011-07       Impact factor: 4.307

6.  Identification of Differentially Expressed Genes under the Regulation of Transcription Factors in Osteosarcoma.

Authors:  Yang Liu; Jianzhong Guan; Xiaotian Chen
Journal:  Pathol Oncol Res       Date:  2018-11-08       Impact factor: 3.201

7.  Dynamics of re-constitution of the human nuclear proteome after cell division is regulated by NLS-adjacent phosphorylation.

Authors:  Gergely Róna; Máté Borsos; Jonathan J Ellis; Ahmed M Mehdi; Mary Christie; Zsuzsanna Környei; Máté Neubrandt; Judit Tóth; Zoltán Bozóky; László Buday; Emília Madarász; Mikael Bodén; Bostjan Kobe; Beáta G Vértessy
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

8.  Hindsight/RREB-1 functions in both the specification and differentiation of stem cells in the adult midgut of Drosophila.

Authors:  Brittany L Baechler; Cameron McKnight; Porsha C Pruchnicki; Nicole A Biro; Bruce H Reed
Journal:  Biol Open       Date:  2015-12-10       Impact factor: 2.422

9.  The cytotoxic role of RREB1, ZIP3 zinc transporter, and zinc in human pancreatic adenocarcinoma.

Authors:  Renty B Franklin; Jing Zou; Leslie C Costello
Journal:  Cancer Biol Ther       Date:  2014-07-22       Impact factor: 4.742

10.  CtBP and associated LSD1 are required for transcriptional activation by NeuroD1 in gastrointestinal endocrine cells.

Authors:  Subir K Ray; H Joyce Li; Eric Metzger; Roland Schüle; Andrew B Leiter
Journal:  Mol Cell Biol       Date:  2014-04-14       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.